Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2026-06-02 17:43:00 ET · period of report 2026-05-29 · accession 0001662103-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 17:43 | 2026-05-29 | CAI | Knowles Jonathan Kenneth Charles | Dir | A - Grant | $15.62 | +1,600 | 309.0K | +0.5% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | A | A | 1,600 | $15.62 | 308,979 | D | — | — | (F1) Shares issued in lieu of cash compensation for 2026 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including May 29, 2026. |